Vaccination against feline retrovirus infections

Abstract

Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV), both of veterinary importance, their antigenic and genetic variability as well as their pathogenicity are described. Disease following FeLV infection is interpreted as a consequence of genetic recombination, as a result of viral evolution in vivo. The principles and efficacy of vaccines are discussed.